Brief: Genetron Health Receives CE Mark For Human B Lymphocyte Minimal Residual Disease Detection Kit SEQ-MRD
19/04/2022 11:15
April 19 (Reuters) - Genetron Holdings Ltd GTH.O :
* GENETRON HEALTH RECEIVES CE MARK FOR HUMAN B LYMPHOCYTE
MINIMAL
RESIDUAL DISEASE DETECTION KIT SEQ-MRD®
Source text for Eikon: ID:nGNX3t6Drs
Further company coverage: GTH.O
Recent news on Genetron Holdings
See all newsBrief: Genetron Holdings Requested That Trading Of Its ADSs On Nasdaq Be Suspended As Of Close Of Trading On March 28, 2024
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius
U.S. STOCKS ON THE MOVE-Scholar Rock, Target, LL Flooring
U.S. STOCKS ON THE MOVE-First Solar, Genetron, Viasat
Genetron surges on $126 mln deal to go private